Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin therapy in inclusion body myositis
2006-005942-35Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of simvastatin in inclusion body myositis (IBM), sponsored by Policlinico Gemelli. Primary endpoint: Functional index improvement. Started Jun 2007; status: completed.
02
Drugs
simvastatin
03
Conditions
inclusion body myositis (IBM)
Beyond the preview
Go deeper on 2006-005942-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005942-35.